Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CI-1040 in Advanced Non-Small Cell Lung, Breast, Colon, or Pancreatic Cancer
NCT00033384Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ci-1040 in non-small cell lung cancer (NSCLC), breast cancer, colon cancer, pancreatic cancer (PC), sponsored by University of Alabama at Birmingham. Started Feb 2002; status: completed.
02
Drugs
ci-1040
03
Conditions
non-small cell lung cancer (NSCLC)breast cancercolon cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00033384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033384.